Logo Polish Statistical Association Polish Statistical Association

Polish Statistical Association

General Board
Aleja Niepodległości 208
00-925 Warszawa

European Statistical Forum - 5th edition

View QR Code A A A save as pdf print

Dear Colleague,

the 5th edition of the European Statistical Forum will be held in Brussels on Monday, 17th November.

In the last years the biostatistics community has increased its interest in the application of Bayesian methodology in drug development as it provides a framework for determining probabilities relevant to inferences from current trials and previous knowledge.

The conference aims at promoting the exchange of expertise in the field coming from academia and industry as well as regulators.

An advanced-draft agenda is now available:

Bruno Boulanger (Arlenda) will show, with practical examples, how Bayesian statistics is a natural way to provide workable solutions and how its application can lead to better decision making and optimised clinical development.

Kathrin Stucke (Boehringer Ingelheim Pharma), Giuseppe Palermo (F.Hoffman-La Roche) and Foteini Strimenopoulou (UCB Pharma) will share experiences about Bayesian dose finding designs in Early Phase development.

Heinz Schmidli (Novartis Pharma) will present the application of Bayesian group sequential designs.

Click here to read the complete agenda and all abstracts.

Free pre-Conference Dinner for registration forms received before June 26th.

For any further information and for registration, please click here to visit the ESF website or do not hesitate to contact us.

We will be glad when you may share this info e mail with your network.

Looking forward to meeting you in Brussels,

With Our Kind Regards,

Enrico Pedroni
Event Manager European Statistical Forum
Tel.: +39.035.515684       Cell.: +39.328.4987130      Fax: +39.035.4501262

Twitter: https://twitter.com/ESF_Forum

The owner of data for the purpose of event registration is Easyb S.r.l.,  with offices at Alzano Lombardo (I) Via Roma, 20,  
who will use your data exclusively for this purpose only. To exercise rights outlined in art. 7 of the Privacy Code and no
longer receive invitation emails, please write to